A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer

NCT00955721 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Lack of Funding

Conditions

Cholangiocarcinoma
Biliary Tract Cancer
Gallbladder Cancer

Interventions

DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Sorafenib

Sponsor

University of Miami